We are very excited to publish nine papers that are not only of the highest quality but also serve as a permanent reminder of the very high standard of research on display at the conference.
analysis including prior specification, hierarchical modeling and random effects. Details of all sessions at the conference can be found at www.amstat.org/meetings/ichps/2011.
Rousing plenary addresses were delivered by Steven Nissen, M.D., Department Chair of Cardiovascular Medicine at the Cleveland Clinic on ''The Drug Safety Wars'', and Arlene Ash, Ph.D., Chief of the Division of Biostatistics and Health Services Research in the Department of Quantitative Health Sciences at the University of Massachusetts Medical School on ''Making Statistics Relevant: Why Not Change The World?'' Dr. Nissen's keynote described the discovery of safety concerns involving the pharmaceutical blockbusters Vioxx, Muraglitazar, and Avandia; the challenge of getting these concerns acknowledged; and subsequent attempted cover-ups. His talk empowered the audience to use rigorous statistical practice to maintain a high standard of integrity. Dr. Ash provided a wonderful description of her work in health policy statistics, offering sage advice and perceptive glimpses of the future. She encouraged the pursuit of problems of real interest, and emphasized the power of independent thought and action.
The conference also featured the presentation of the Health Policy Statistics Section's biennial Awards. Honored with the Long-Term Excellence Award were Drs. Paula Diehr (University of Washington, emeritus) and Sharon-Lise Normand (Harvard University), while the Mid-Career Award was presented to Dr. James O'Malley (Harvard University). A Thursday evening visit to the House of Blues and Cleveland's East Fourth Street district afforded opportunities to mingle in a relaxed environment while enjoying Cleveland's hospitality and delicious food.
The eleven conference workshops (together attracting nearly 500 attendees) included sequences on causal inference and patient reported outcomes, plus workshops on quantile regression, multiple comparisons, network meta-analysis, and evaluating the accuracy of medical tests and biomarkers. Jeffrey Rhoades from AHRQ concluded the conference with an entertaining and informative introduction to the Medical Expenditure Panel Survey.
This ICHPS was delighted to provide 15 student travel awards, supported by multiple industry and academic partners, including Lilly USA, Harvard Clinical Research Institute (HCRI), Valence Health, Millennium Pharmaceuticals, and ASA's Cleveland Chapter as well as Case Western Reserve University's Department of Epidemiology & Biostatistics, the Cleveland Clinical and Translational Science Collaborative and the Center for Health Care Research and Policy. In addition, the Conference Chairs were grateful for ASA's outstanding support, and in particular, for the stellar work of the conference's planner, Lisette Werbowetzki.
We eagerly anticipate the tenth ICHPS, planned for October 2013. For more information, contact Conference Chairs Andrew Zhou (azhou@u.washington.edu) and Donald Hedeker (hedeker@uic.edu).
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